MedTrace Logo

Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA)

NCT03014180 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-05-28

Study results available
· View outcomes & findings →

Summary

The purpose of the LEVEA study is to assess the performances of a new automatic left ventricular auto threshold (LVAT) algorithm (In-Clinic LVAT algorithm) when used by physicians during in-hospital follow-up.

Conditions

Interventions

DEVICE

"In-Clinic LVAT"

Algorithm offers automatic threshold measurement of differents vectors of left ventricular stimulation.

Sponsors & Collaborators

  • LivaNova

    lead INDUSTRY

Principal Investigators

  • Jacques Mansourati, Pr · CHRU de Brest, FRANCE.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-16
Primary Completion
2017-08-17
Completion
2017-08-17

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014180 on ClinicalTrials.gov